Cargando…
Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.
Antibodies specific for human p53 were analysed in sera of lung cancer patients. We detected p53 antibodies in the sera of 24% (10/42) of patients with lung carcinoma. The distribution was as follows: 4/9 small-cell lung carcinomas (SCLCs), 2/18 squamous cell lung carcinomas (SCCs), 2/10 adenocarcin...
Autores principales: | Schlichtholz, B., Trédaniel, J., Lubin, R., Zalcman, G., Hirsch, A., Soussi, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968913/ https://www.ncbi.nlm.nih.gov/pubmed/7514026 |
Ejemplares similares
-
Serum p53 antibodies: predictors of survival in small-cell lung cancer?
por: Murray, P V, et al.
Publicado: (2000) -
Understanding p53 functions through p53 antibodies
por: Sabapathy, Kanaga, et al.
Publicado: (2019) -
Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001) -
Corrigendum to ‘Understanding p53 functions through p53 antibodies’
por: Sabapathy, Kanaga, et al.
Publicado: (2019) -
Sera Anti-P53 Antibody Provides New Information Which Explains the Link Between Diabetes and Cancer
por: Sauriasari, Rani, et al.
Publicado: (2020)